SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

25 Sep 2012 07:00

RNS Number : 0548N
Rentokil Initial PLC
25 September 2012
Β 

ο»Ώ

Β 

Β 

Β 

25 September 2012

Β 

Rentokil Initial acquires the assets of Western Exterminator Company

Β 

Rentokil Initial plc ("Rentokil") (LSE: RTO) today announces that it has agreed to acquire the assets of Western Exterminator Company ("Western"), a leading pest control company on the US West Coast, for an initial cash consideration of $99.6m, with a deferred consideration of up to $15.0m payable within 18 months, from existing financial facilities.

Β 

Rentokil will become the third largest pest control company in the North American market with pro-forma annualised revenues of $330m in pest control services (with coast to coast coverage) and $90m in speciality chemical products distribution.

Β 

Western has two divisions:

Β 

Β·; The Pest Control division has 36 offices located primarily in California and the adjacent states of Arizona and Nevada. It provides Rentokil with an entrance into these states with a population of 46m people.

Β 

Β·; The Products division is a leading wholesale distributor of specialty chemicals serving the West Coast and central regions of the US, providing products and supplies to the pest control, landscape, golf course and nursery industries. This division complements our existing specialty chemical products division which serves the East Coast of the US.

Β 

The acquisition is consistent with Rentokil's strategy, outlined in November 2011, of targeting pest control acquisitions in North America, Latin America and the Middle East.

Β 

The total book value of the gross assets to be acquired is $36.7m. In the year to 31 December 2011 the business acquired generated EBITA of $4.1m on revenues of approximately $149.0m (60% Pest Control: 40% Products).

Β 

The deferred consideration will be payable subject to certain working capital and other adjustments, including warranty and/or indemnity claims.

Β 

The acquisition is expected to complete later this year subject to receipt of the relevant regulatory clearances. The transaction will be EPS accretive in year one. The profitability of Western will be improved significantly by leveraging Rentokil's commercial and operational management capabilities to bring Western's operating margins into line with Rentokil's current North American Pest Control business.

Β 

Alan Brown, Chief Executive of Rentokil Initial plc, said:

Β 

"This acquisition significantly increases Rentokil's footprint in the World's largest pest control market and enables us to compete more effectively, particularly for customers looking for nationwide coverage in pest control or specialty chemical distribution capability.

Β 

"Western has service and quality levels that are among the best in the industry. It is rightly proud of its 90-year tradition and reputation.

Β 

"We have taken our US Pest Control and Products business from revenue of less than $30million to $420million through a series of successful acquisitions, most notably JC Ehrlich, Presto-X and now Western over the last seven years."

Β 

Ends

Note: A presentation with additional information about Western Exterminator can be found at www.rentokil-initial.com/investors/presentations

Β 

About Rentokil Initial plc

Β 

Rentokil Initial is one of the largest business services companies in the world, operating in all the major economies of Europe, North America, Asia Pacific and Africa. The Company has some 66,000 employees providing a range of support services in over 60 countries.

Β 

www.rentokil-initial.com

Β 

www.westernexterminator.com

Β 

www.target-specialty.com

Β 

Β 

Enquiries:

Β 

Investors / Analysts enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 01293 858 166

Β 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Kate Holgate/ Catriona McDermott Brunswick Group 020 7404 5959

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQUVUSRUWAKURR
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.